Navigation Links
BUSM researchers identify better laser for treating facial spider veins
Date:10/6/2009

(Boston) - Researchers from Boston University School of Medicine (BUSM) have concluded that the 940nm wavelength laser is superior for treating facial spider veins (telangiectasias) as compared to the 532nm wavelength laser. The findings, which appear in the recent issue of Lasers in Surgery and Medicine, are the first time these lasers were tested against each other for superiority.

Telangiectasias are open (dilated) blood vessels in the outer layer of the skin usually caused by sun damage or aging. When appearing on the legs, they are often called spider veins. They are common to a number diseases, including acne, rosacea, birthmarks (port-wine stains), scleroderma, several types of inherited disorders (ataxia-telangiectasia, hereditary hemorrhagic telangiectasia, xeroderma pigmentosum, and others), or with prolonged use of oral or topical corticosteroids.

According to the researchers, while both the 532 and 940nm wavelength lasers are effective for facial telangiectasias, they lacked evidence to support whether one wavelength was superior to the other until now.

A total of 24 facial anatomic sites were treated with the 532 and the 940nm wavelength lasers. The presence and severity of side effects such as pain, erythema, crusting, swelling and blistering were assessed.

The researchers found pain associated with the laser treatment was significantly less for the 940nm wavelength compared to the 532nm wavelength. Erythema post-treatment was significantly less with 940nm relative to 532 nm. Significant crusting and swelling were only reported with the 532nm wavelength. Visual improvement with the 940nm wavelength was greater than that achieved with the 532nm wavelength. On photographic evaluation, the 940nm laser was significantly more efficacious for larger caliber vessels than 532nm. Both wavelengths were equally effective for smaller caliber vessels.

"The 940nm diode laser was found to have greater efficac
'/>"/>

Contact: Gina M. DiGravio
gina.digravio@bmc.org
617-638-8480
Boston University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Toronto researchers discover novel circulation in human eye, new glaucoma treatment target
2. Researchers find demand for cosmetic and surgical procedures in dermatologic surgery rising rapidly
3. Using synthetic evolution to study the brain: Researchers model key part of neurons
4. Researchers at Boston University School of Medicine incorporate multisite geriatric clerkship
5. Researchers use computational models to study fear
6. Researchers develop an integrated treatment for veterans with chronic pain and posttraumatic stress
7. UT Houston, Jamaica researchers launch autism study
8. Paul Marks prize recognizes 3 young cancer researchers
9. Van Andel Institute researchers find gene that could lead to new therapies for bone marrow disease
10. Mayo researchers find few side effects from radiation treatment given after prostate cancer surgery
11. U of T researchers create microchip that can detect type and severity of cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... 02, 2015 The National Association ... as a 2015-2016 inductee into its VIP Woman ... prestigious distinction for leadership in business. NAPW is the ... more than 700,000 members and over 200 operating Local ... important honor,” said NAPW President Star Jones. “Her perseverance, ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 Carson Energy ... facilitate their investors IRA transactions. AdvantaIRA Trust, LLC is ... investors the ability to fund positions using IRA’s does ... participate on a project, even if there current cash ... an additional funding source for Carson and their investors ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 The Delta ... health programs and organizations in Michigan, Ohio and Indiana ... deadline of Sept. 30, 2015 has been set. , ... in grants to organizations that specifically focus on children’s ... primarily address oral health in adults. Each grant request ...
(Date:6/1/2015)... June 01, 2015 EBSCO Health ... today introduced DynaMed Plus™ , a cross-platform evidence-based ... professionals. It provides clinicians with the ideal blend of ... care paths. , DynaMed Plus is a significant ... includes the most frequently updated evidence-based content. DynaMed Plus ...
(Date:6/1/2015)... KC and Monica Craichy, Founders of ... best superfood products in the world to ... , "Monica and I are excited to be ... Living Fuel Super Meals - SuperBerry®, SuperGreens and LivingProtein® ... Texas," KC Craichy said. "We have attempted to do ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Linda Cade, Senior Product Manager at Sage, Into its VIP Professional Woman of the Year Circle 2Health News:Carson Energy Brings Oil Wells To IRAs 2Health News:Brighter Futures Community Grants Program Seeks to Help Fund Local Oral Health Programs 2Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 2Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 3Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 4Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 2Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 3
... bone marrow, and known as MAPCs, have proved to ... and also in muscle tissue when treating peripheric vascular ... mouse models by two research groups, one by the ... Applied Medical Research (CIMA), also of the University of ...
... font of all knowledge, despite the plethora of information ... of New South Wales (UNSW) in Australia have found ... of useful materials, people pay more attention to information ... read the right material, they are stubborn to changing ...
... continuing operations, excluding ... guidance for full fiscal year 2008 earnings per share from, continuing operations, excluding specified ... ... N.J., Jan. 24 BD (Becton,Dickinson and Company) (NYSE: BDX ) today reported ...
... Allergy Friendly" Certification Now Available, WASHINGTON, ... product Certification Program administered by the,Asthma and ... with the,international research organization, Allergy Standards Limited ... & allergy friendly(TM) products., (Photo: ...
... formulation temporarily reserved for patients with Acute Myelogenous Leukemia ... transplantation graft failure or ... aims to restore US supplies ... WAYNE, N.J., Jan. 23 Bayer HealthCare Pharmaceuticals,Inc. announced today, ...
... Pa., Jan. 23 Pennsylvania,AFL-CIO President William George ... the latest decisions by,Representatives John Peterson, Joseph Pitts, ... insurance for millions of children in,families hit hardest ... see how, in the face of a severe ...
Cached Medicine News:Health News:Adult stem cell application effective in treatment of peripheric vascular disease 2Health News:Adult stem cell application effective in treatment of peripheric vascular disease 3Health News:Why the Web tells us what we already know 2Health News:BD Announces Results For First Fiscal Quarter 2Health News:BD Announces Results For First Fiscal Quarter 3Health News:BD Announces Results For First Fiscal Quarter 4Health News:BD Announces Results For First Fiscal Quarter 5Health News:BD Announces Results For First Fiscal Quarter 6Health News:BD Announces Results For First Fiscal Quarter 7Health News:BD Announces Results For First Fiscal Quarter 8Health News:BD Announces Results For First Fiscal Quarter 9Health News:BD Announces Results For First Fiscal Quarter 10Health News:Asthma Foundation Expands Certification Program to be 'Friendly' to Millions More 2Health News:Bayer Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation 2Health News:Bayer Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation 3Health News:Bayer Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation 4Health News:Pennsylvania AFL-CIO Decries Shameful Votes Again by Representatives John Peterson, Joe Pitts and Bill Shuster, Against Children's Health Care 2
(Date:6/1/2015)... ENCINO, Calif. , June 1, 2015  Research ... to scientific, technical and medical (STM) information for life ... has been invited to present at the LD Micro ... Luxe Hotel in Los Angeles ... scheduled to present on Wednesday, June 3rd at 9:30 ...
(Date:6/1/2015)... 1, 2015  Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ) ... known as ,nal-IRI, in a Phase 1 investigator-sponsored study ... glioma. Data were presented at the 2015 American Society ... Chicago, IL. Results from this study show ... high-grade glioma when given intravenously.  Based in ...
(Date:6/1/2015)... , June 1, 2015 ... weight over large area and improve the quality life ... ulcer. These devices play a significant role in inhibiting ... reduce the need to turn or rotate an immobile ... include mattress, mattresses overlay, and specialty beds. These devices ...
Breaking Medicine Technology:Research Solutions to Present at the LD Micro Invitational on June 3, 2015 2Research Solutions to Present at the LD Micro Invitational on June 3, 2015 3Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 2Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 3Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 4Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 5Global Pressure Relief Devices Market 2015-2019 2Global Pressure Relief Devices Market 2015-2019 3
... Inc. (NYSE: WST ) today announced that Donald E. ... Federici, Chief Financial Officer, will attend the Lazard Capital Markets ... present an overview of West,s business and outlook on Tuesday, ... of the corporate presentation document as well as a live ...
... Ill., Nov. 12 Nearly one in three adult Americans ... 34 million have low HDL "good" cholesterol levels. To ... Abbott has launched two Web sites: www.knowyourhdl.com ... triglyceride and low HDL levels are factors that can raise ...
Cached Medicine Technology:New Web Sites Educate About Triglycerides and HDL Cholesterol 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: